Sterling Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.39K Sell
77
-58
-43% -$5.95K ﹤0.01% 2392
2026
Q1
$14.7K Sell
135
-4
-3% -$381 ﹤0.01% 2170
2025
Q4
$11.3K Buy
139
+88
+173% +$7.58K ﹤0.01% 2547
2025
Q3
$4.46K Buy
51
+2
+4% +$179 ﹤0.01% 2795
2025
Q2
$4.07K Buy
49
+28
+133% +$2.34K ﹤0.01% 2623
2025
Q1
$1.76K Hold
21
﹤0.01% 2637
2024
Q4
$1.94K Hold
21
﹤0.01% 2794
2024
Q3
$1.95K Buy
+21
New +$1.82K ﹤0.01% 2195

Other funds holding LMAT

Sterling Capital Management's LMAT Position: Q2 2026 in Review

Sterling Capital Management reduced its LeMaitre Vascular (LMAT) stake by 43% in Q2 2026, selling an estimated $5.95K and leaving 77 shares worth $7.39K. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

Sterling Capital Management first reported a position in LMAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.7K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Sterling Capital Management held 77 shares of LeMaitre Vascular worth $7.39K as of Q2 2026.
  • Sterling Capital Management sold 58 LeMaitre Vascular shares in Q2 2026, an estimated $5.95K.
  • LeMaitre Vascular made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2392 holding.
  • Sterling Capital Management first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's LeMaitre Vascular position peaked at $14.7K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.